Alexander M Lesokhin

52PUBLICATIONS
199CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMedical bacteriologyGene expression (incl. microarray and other genome-wide approaches)Food properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Aug 19, 2026
Lesion-level PET/CT analysis to identify predictors of progression after BCMA CAR T-cell therapy in multiple myeloma.

|Jul 22, 2026
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial.

|Jul 20, 2026
Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.

|Jun 12, 2026
Genomic features do not account for differences in multiple myeloma risk by ancestry.

|May 01, 2026
A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients.

|Apr 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve

Pageof 9

Frequent Collaborators

29 joint publications

Urvi Shah

24 joint publications

Kylee Maclachlan

24 joint publications

Heather Landau

23 joint publications

Neha Korde